Authors
Loading...
Investigations reveal how EZH2 and DRD1 signaling affects tumor behavior in triple-negative breast cancer, suggesting novel treatment targets.
Pietrzak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: